High Levels of NRF2 Sensitize Temozolomide-Resistant Glioblastoma Cells to Ferroptosis via ABCC1/MRP1 Upregulation

Two human glioblastoma cell lines were examined after treatment with temozolomide, ferroptosis inducers, and ferroptosis inhibitor.